| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2171613 | Cytotherapy | 2012 | 10 Pages |
Abstract
Background aimsWe have recently shown that thymoglobulin (TG) efficiently expands cytokine-induced killer (CIK) cells in combination with interferon (IFN)-γ and interleukin (IL)-2 (ITG2 protocol). It is presently unknown whether the infusion of autologous immune effector cells generated by TG, IFN-γ and IL-2 is feasible and safeMethodsFive patients with advanced and/or refractory solid tumors
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Sergio Rutella, Paola Iudicone, Giuseppina Bonanno, Daniela Fioravanti, Annabella Procoli, Claudio Lavorino, Maria Laura Foddai, Domenica Lorusso, Enrica Martinelli, Michele Vacca, Francesco Ipsevich, Marianna Nuti, Giovanni Scambia, Luca Pierelli,